Botulinum toxin treatment for esophageal achalasia
Record ID 32011000879
English
Authors' objectives:
Botulinum toxin (BTX) is used for the endoscopic treatment of esophageal achalasia, characterized by sphincteric spasticity. BTX is injected directly into the lower esophageal sphincter in order to produce chemical denervation of the abnormally functioning muscles by blocking synaptic transmission. This relaxes the muscle and causes a temporary relief of pain and other symptoms.
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
http://www.hayesinc.com/hayes/crd/?crd=11817
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Botulinum Toxins
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2010 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.